A guide to preparation of patients with inflammatory bowel diseases for anti-TNF-α therapy

Current therapy of moderate-to-severe inflammatory bowel disease (IBD) often involves the use of anti-tumor necrosis factor alpha (TNF-α) agents. Although very effective, theses biologics place the patient at increased risk for developing infections and lymphomas, the latter especially when in combi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chebli, Júlio Maria Fonseca, Gaburri, Pedro Duarte, Chebli, Liliana Andrade, da Rocha Ribeiro, Tarsila Campanha, Pinto, André Luiz Tavares, Ambrogini, Orlando, Damião, Adérson Omar Mourão Cintra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2014
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972052/
https://www.ncbi.nlm.nih.gov/pubmed/24667275
http://dx.doi.org/10.12659/MSM.890331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972052/
https://www.ncbi.nlm.nih.gov/pubmed/24667275
http://dx.doi.org/10.12659/MSM.890331

Ejemplares similares